Pharmacotherapy Handbook 9th Edition Pdf 2015 59
Fabulously Favuzza
This European Society of Cardiology (ESC) Handbook on Cardiovascular Pharmacotherapy has been developed by experts from the ESC Working Group on Cardiovascular Pharmacotherapy. Its recommendations are aligned with the ESC Clinical Practice Guidelines and based on the most recent scientific evidence in cardiovascular pharmacology and pharmacotherapy.
The handbook provides up-to-date information on pharmacotherapy for cardiovascular disease prevention, and treatment of cardiovascular disease, including ischaemic heart disease, heart failure, arrhythmias, and structural heart disease.
The handbook also deals with the important problems of cardiovascular pharmacotherapy in pregnancy and lactation, kidney insufficiency, and liver disease as well as focusing on major drug interactions, a topic of extreme importance in clinical practice.
The handbook represents essential reading for cardiologists, general practitioners, internal medicine specialists, anaesthetists, clinical pharmacologists, geriatricians, obstetricians, and cardiovascular nurse consultants. Junior doctors and trainees in all these specialties are also likely to find this book of help.
Reviewer: Yen Dang, PharmD (University of Maryland Eastern Shore)
Description: This handbook provides an overview and summary of the management of key disease states. It offers essential information that healthcare professionals can use to identify and treat medical conditions. This 12th edition is an update to the previous version, which was published in 2021.
Purpose: The purpose of the book is to provide convenient, concise therapeutics information that healthcare professionals can use to make clinical decisions. These are worthy objectives, as the parent DiPiro textbook is lengthy. The handbook meets its objectives, as it organizes information such that the drug and disease information is readily accessible in a manageable, user-friendly format.
Audience: The book is written for clinicians, including pharmacists, pharmacy students, and other healthcare professionals. The book meets the needs of its audience by organizing information in a consistent format. The authors are credible as leading experts in the field of pharmacy practice, and the information is regularly updated.
Features: The handbook provides a concise overview of DiPiro's Pharmacotherapy textbook to enable readers to access the information in a concise guide. It covers content for 149 medical conditions organized by disease state definition, pathophysiology, clinical presentation, diagnosis, treatment, and evaluation of therapeutic outcomes. The information is presented in tables, figures, treatment algorithms, charts, and text.
Assessment: This handbook provides reliable, up-to-date medical information in a consistent format for healthcare professionals to easily access. The information is organized by disease state chapters with data presented in a manageable manner. This edition is needed, as it covers drug and medical guideline updates since the 11th edition and offers new chapters on COVID-19 and multiple sclerosis.
4 STAR DOODY'S REVIEW
"The book addresses all aspects of 84 disease states and disorders, from presentation and pathology to treatment and monitoring. Each chapter focuses on individual groups of medication considered for treatment and gives a concise overview of them in easy to see bulleted points. The qualities that I find especially useful are that charts and algorithms are easily identifiable and tables are shaded light gray for quick reference . . . Although this handbook contains an enormous amount of information, it conveniently fits into a lab coat pocket. It is an extremely useful reference." -- Doody's
Wells' expertise is in the areas of psychiatric pharmacotherapy and women's health. Much of her work also deals with leadership in the health professions, pharmacy education and in advocacy for the profession. Her research has examined drug-drug interactions of psychotropic medications and the clinical management of depression, anxiety disorders and schizophrenia.
Wells, who once directed a residency program in psychiatric pharmacy practice and a fellowship program in psychiatric pharmacotherapy, was a founding member of the CPNP in 1998. She has been dean, a professor and executive director of the Research Institute of Pharmaceutical Sciences at the UM pharmacy school since 2001.
Robinson graduated with her Doctor of Pharmacy degree from WSU in 2005. She was the manager of Jones Pharmacy in Spokane, Washington, until 2008 when she joined the faculty at WSU. She is a clinical associate professor in the department of pharmacotherapy.
aa06259810